| Stage | SPCX | % of rev | TSLA | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $14.6B | 100.00% | $28.0B | 100.00% | TSLA ×1.92 |
| Gross profit | $9.1B | 62.42% | $5.5B | 19.59% | SPCX +42.8pp |
| Operating income | $2.8B | 19.15% | $718M | 2.56% | SPCX +16.6pp |
| Pre-tax income | $4.0B | 27.54% | $956M | 3.41% | SPCX +24.1pp |
| Net income | $4.4B | 30.22% | $804M | 2.87% | SPCX +27.3pp |
| Stage | SPCX | TSLA | Gap · A − B |
|---|---|---|---|
| Revenue | $14.6B100.00% | $28.0B100.00% | TSLA ×1.92 |
| Gross profit | 62.42%$9.1B | 19.59%$5.5B | SPCX +42.8pp |
| Operating income | 19.15%$2.8B | 2.56%$718M | SPCX +16.6pp |
| Pre-tax income | 27.54%$4.0B | 3.41%$956M | SPCX +24.1pp |
| Net income |
| 30.22%$4.4B |
| 2.87%$804M |
| SPCX +27.3pp |
No shared counterparties.